1. P.J. Thornalley, N. Ahmed and O.K. Argirov. Assay of advanced glycation endproducts in proteins. Priority file May 2000.
  2. P.J. Thornalley, N. Ahmed and O.K. Argirov. Novel therapeutic agent for the vascular complications of diabetes. Priority file September 2000.
  3. P.J. Thornalley, N. Rabbani and M. Xue. (2011) Prevention of proteomic and genomic damage by dicarbonyl substrates of Glo 1. WO 2011161436.
  4. R.S. Savage, U. Ahmed, N. Rabbani and P.J. Thornalley. Diagnostic for Determining Skeletal Health. (2014) WO2014016584 A2. Priority file: July 2012.
  5. P.J. Thornalley and N. Rabbani. (2014) Quantitation and imaging of methylglyoxal and related dicarbonyls by fluorogenic derivatizing agents. WO 2014037697. Priority file: September 2012.
  6. P.J. Thornalley, N. Rabbani, R.S. Savage and U. Ahmed. Markers for skeletal disorders. WO 2017149300. Priority file: March 2016.
  7. Fowler, M.I., Jenkins, G., Messenger, D.J., Xue, M., Rabbani, N. and Thornalley, P.J. Composition for hair follicle growth. WO2017080958. Priority file November 2015.
  8. Masania, J., Rabbani, N., Thornalley, P.J., Rajpoot, N., Rajpoot, K., Winklhofer-Roob, B.M., Roob, J. and Faustmann, G. Biomarkers of impaired health. Patent Application No. 1721723.3.
  9. Rabbani, N., Thornalley, P.J., Rajpoot, K. and Marini, M. Method of diagnosis of autistic spectrum disorder. Priority file January 2018.
  10. Rabbani, N., De la Fuente, A. and Thornalley, P.J., Blood and urine-based test for prediction of progression of diabetic kidney disease. Filed December 2020.